Early Appearance of Myocardial Fibrosis in Restrictive Diabetic Cardiomyopathy
- 1 July 2023
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 16 (7) , 554-556
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart FailureCirculation, 2019
- Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes MellitusCirculation, 2019
- IL-1 Blockade in Patients With Heart Failure With Preserved Ejection FractionCirculation: Heart Failure, 2018
- Metabolic Syndrome Is Associated With Impaired Diastolic Function Independently of MRI-Derived Myocardial Extracellular Volume: The MESA StudyDiabetes, 2018
- Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection FractionJACC: Heart Failure, 2018
- Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection FractionJAMA Cardiology, 2017
- Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection FractionJACC: Heart Failure, 2017
- Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypesEuropean Heart Journal, 2015
- Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection FractionCirculation: Heart Failure, 2011
- Diastolic Stiffness of the Failing Diabetic HeartCirculation, 2008